Company / Return on Equity (ROE)
ACCENDRA HEALTH INC/VA/ Return on Equity (ROE) History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
-61.9%
FY2024
5-year range
-61.9% / 2.3%
FY2020-FY2024
Trend
-1315.3%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
ACCENDRA HEALTH INC/VA/ reports negative total equity of -61.9% in FY2024. Negative equity can occur when accumulated losses exceed contributed capital, as reported in the balance sheet from the SEC filing.
Based on SEC 10-K filings.
-61.9% in FY2024 with a 5-year CAGR of +22.4%.
Declined from 2.3% to -61.9% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- -48.4pp
- 5-Year Change
- +22.4pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, return on equity (roe) decreased 1315.3% year-over-year.
- Peak return on equity (roe) was recorded in FY2016.
- Lowest return on equity (roe) in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.60 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -61.9% | -1315.3% |
| FY2023 | -4.4% | -288.4% |
| FY2022 | 2.3% | +117.2% |
| FY2021 | -13.5% | -421.4% |
| FY2020 | 4.2% | +105.0% |
| FY2019 | -84.3% | +0.0% |
| FY2018 | -84.3% | -1275.7% |
| FY2017 | 7.2% | -36.7% |
| FY2016 | 11.3% | +8.7% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026